Role of Xanthine Oxidase and Eicosanoids in Development of Pancreatic Ischemia-Reperfusion Injury

G. Hotter, D. Closa, E. Gelpí, N. Prats, J. Roselló-Catafau

    Producció científica: Contribució a una revistaArticleRecercaAvaluat per experts

    14 Cites (Scopus)

    Resum

    The implication of different eicosanoids and oxygen free radicals in the development of pancreatic injury after an ischemia-reperfusion process has been evaluated. For this purpose we have compared the effect of allopurinol and indomethacin administration on the pancreatic levels of eicosanoids in a rat model of pancreatic ischemia-reperfusion. After 60 min of pancreatic ischemia and 2 h of reperfusion, significant increases in 6-keto-PGF1α, PGE2, and LTB4 in pancreas tissue were detected. Allopurinol before the ischemic period reduced 6-keto-PGF1α, PGE2, and LTB4 levels to the range of basal values, while prior indomethacin treatment significantly reduced 6-keto-PGF1α and PGE2 levels, with LTB4 remaining unmodified. Increased postischemic plasma lipases were also significantly reduced by allopurinol to the range of sham-operated animals whereas indomethacin did not modify these levels. The data suggest a role for lipoxygenase metabolites in the development of pancreatic injury and the importance of the enzyme xanthine oxidase as an inductor of eicosanoid biosynthesis. © 1995 Plenum Publishing Corporation.
    Idioma originalEnglish
    Pàgines (de-a)469-478
    RevistaInflammation
    Volum19
    Número4
    DOIs
    Estat de la publicacióPublicada - 1 d’ag. 1995

    Fingerprint

    Navegar pels temes de recerca de 'Role of Xanthine Oxidase and Eicosanoids in Development of Pancreatic Ischemia-Reperfusion Injury'. Junts formen un fingerprint únic.

    Com citar-ho